Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Diloxanide adverse reaction (disorder) |
Causative agent (attribute) |
True |
Diloxanide (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Allergy to diloxanide |
Causative agent (attribute) |
False |
Diloxanide (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing diloxanide furoate |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Diloxanide (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely diloxanide 250 milligram and metronidazole 200 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Diloxanide (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Diloxanide furoate 500mg tablet (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Diloxanide (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Diloxanide furoate 250mg tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Diloxanide (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing diloxanide and metronidazole (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Diloxanide (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Diloxanide (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Diloxanide (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Diloxanide furoate 250mg tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Diloxanide (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Diloxanide furoate (substance) |
Is a |
False |
Diloxanide (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Allergy to diloxanide |
Causative agent (attribute) |
True |
Diloxanide (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Diloxanide-containing product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Diloxanide (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely diloxanide 250 milligram and metronidazole 200 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Diloxanide (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely diloxanide 250 milligram and metronidazole 200 milligram/1 each conventional release oral tablet (clinical drug) |
Has basis of strength substance (attribute) |
False |
Diloxanide (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Diloxanide furoate (substance) |
Is modification of (attribute) |
True |
Diloxanide (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely diloxanide 250 milligram and metronidazole 200 milligram/1 each conventional release oral tablet (clinical drug) |
Has precise active ingredient |
False |
Diloxanide (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing diloxanide and metronidazole in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Diloxanide (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing only diloxanide (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Diloxanide (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Diloxanide and metronidazole only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Diloxanide (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing only diloxanide in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Diloxanide (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Diloxanide and metronidazole only product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Diloxanide (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing precisely diloxanide 250 milligram and metronidazole 200 milligram/1 each conventional release oral tablet (clinical drug) |
Has precise active ingredient |
True |
Diloxanide (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing precisely diloxanide 250 milligram and metronidazole 200 milligram/1 each conventional release oral tablet (clinical drug) |
Has basis of strength substance (attribute) |
True |
Diloxanide (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |